Views & Analysis | Perspectives on pharma industry issues

Skip to main content

Thursday 8 October 2026

BlueSky linkedin youtube

header links

Get Newsletters
Media Kit

Pharmaphorum menu first category

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
Spotlight on
Events

close

SECTION

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

Channels

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

SUB NAVIGATION

Live Coverage
Partner Content
About us
Work for us
Contribute
Contact us
Advertise

Newsletters and Deep Dive digital magazine

youtube linkedin BlueSky

Digital

US big tech losing trust

The politics of global AI: US tech leaders must listen to th...

Reliance on US big tech is now being challenged around the world at a time when geopolitical instability is eroding global trust in US leadership.

Sales & Marketing

Klick Health and Oxford PharmaGenesis

Why Klick Health, Oxford PharmaGenesis chose to join forces

Leadership from Klick Health and Oxford PharmaGenesis discuss their June acquisition and what the newly combined company brings to the market.

Sales & Marketing

Day One Strategy white paper

Sponsored

Are Insights leaders seeing real commercial value from AI ad...

Day One Strategy’s second annual AI in Pharma State of Play report addresses the challenges Pharma Insights teams are facing as AI adoption continues.

R&D

LSX 2026 with Sam Possemiers, MRM Health

Taking the microbiome seriously, with Sam Possemiers

pharmaphorum catches up with MRM Health founder and CEO Sam Possemiers at LSX 2026.

Sales & Marketing

pharmaphorum podcast Episode 279

AI and pharma launch - Within3’s Jason Smith

Jason Smith, CTO of AI and analytics at Within3, discusses data-fuelled agile launches and smarter decision-making.

Views & Analysis

Coronavirus pharma news roundup

Coronavirus pharma news roundup – 24/04/2020

Research into drugs that could treat or prevent COVID-19 continued full steam ahead this week as the industry puts all its resources into fighting the coronavirus pandemic.

Views & Analysis

COVID-19 and premature babies: Locking down to protect their future

COVID-19 and premature babies: Locking down to protect their...

Everyone is living with a certain degree of COVID-19-related fear and anxiety at the moment – but spare a thought for the parents of premature and sick babies.

Views & Analysis

Coronavirus vaccine: how pharma is picking up the pace

Coronavirus vaccine: how pharma is picking up the pace

The world is waiting with bated breath for a coronavirus vaccine, which has become one of the most sought-after pharmaceutical products of the last century.

Load more results

Sales & Marketing

Sales & Marketing

Klick Health and Oxford PharmaGenesis

Why Klick Health, Oxford PharmaGenesis chose to join forces

Leadership from Klick Health and Oxford PharmaGenesis discuss their June acquisition and what the newly combined company brings to the market.

Sales & Marketing

Day One Strategy white paper

Sponsored

Are Insights leaders seeing real commercial value from AI ad...

Day One Strategy’s second annual AI in Pharma State of Play report addresses the challenges Pharma Insights teams are facing as AI adoption continues.

Digital

Digital

US big tech losing trust

The politics of global AI: US tech leaders must listen to th...

Reliance on US big tech is now being challenged around the world at a time when geopolitical instability is eroding global trust in US leadership.

Digital

Axtria HIQ - Solution Spotlight

Sponsored

Solution Spotlight: Axtria HIQ

Axtria HIQ is an agentic analytics product built specifically for pharmaceutical headquarters teams.

Market Access

Market Access

health leadership team in discussion

Beyond Market Access: Why healthcare-system understanding is...

Healthcare-system literacy, and the ability to contribute to system shaping, must become part of how healthcare leaders make decisions.

Market Access

Chinese flag atop pills on black background

Is the next generation of Chinese biotech ready to go global...

Will Chinese biotechs continue to transfer most ex-China rights, or retain their strongest assets and compete internationally themselves?

Editor's Picks

AbbVie's Cerevel takeover delivers Parkinson's approval

FDA clears first drug for MCT8 deficiency

Novartis taps China's Abogen for autoimmunity TCE

AZ takes stake in Summit Therapeutics in $2bn deal

PhRMA hires ex-House Majority Leader Eric Cantor as its CEO

Newsletters and Deep Dive
digital magazine

Get Newsletters

Get in-depth news, opinions, and features on pharma and healthcare sent straight to your inbox

Oncology

Oncology

Dr Michael Bauer and Jonah Comstock

Dr Michael Bauer on Quantro’s mission to drug the “undruggab...

Jonah Comstock reunited with Dr Michael Bauer, CEO of Quantro Therapeutics, at LSX 2026 to discuss the company's progress.

Oncology

Cancer cell and T-cells

In vivo CAR-T can solve the delivery problem – but solid tum...

A new generation of in vivo CAR-T cell technologies promises to remove some of the biggest practical barriers to conventional cell therapy.

Oncology

T-cells in action

Unlocking the scalability of allogeneic CAR-T

Allogeneic CAR-T, built from healthy donor T-cells, offers a different path toward scale, accessibility, and consistency.

Patients

Patients

Union Jack on pill, one of many scattered on aqua surface

Rare diseases, real opportunity: Why the UK’s next challenge...

The UK has the science, the talent, and the investment. The next step is ensuring that innovation translates into timely patient impact.

Patients

oral GLP-1

Maintenance: The underexamined half of the GLP-1 story

GLP-1 treatments have historically had an exit problem, as appetite suppression stops when the medication stops.

Patients

World Patient Safety Day 17th September

Why patient safety doesn't end at approval

Once a treatment becomes available to the public, protecting patient safety remains a priority throughout its time on the market.

R&D

R&D

LSX 2026 with Sam Possemiers, MRM Health

Taking the microbiome seriously, with Sam Possemiers

pharmaphorum catches up with MRM Health founder and CEO Sam Possemiers at LSX 2026.

R&D

Digital representation of sepsis bacteria attacking heart

The hidden pandemic within the pandemic: How COVID-19 impact...

Why sepsis readiness – equipment, supply chains, surveillance, and public awareness – needs to be treated as core pandemic infrastructure.

R&D

Silhouette of a head with white brain under magnifying glass inside outline, against yellow background

Alzheimer’s: Starting the impossible journey

September was Alzheimer’s Month, and with that in mind pharmaphorum spoke to leaders at two biotechs about latest developments in the field.

Editor's Picks

AbbVie's Cerevel takeover delivers Parkinson's approval

FDA clears first drug for MCT8 deficiency

Novartis taps China's Abogen for autoimmunity TCE

AZ takes stake in Summit Therapeutics in $2bn deal

PhRMA hires ex-House Majority Leader Eric Cantor as its CEO

News

Rhapsido is first drug cleared for chronic hives disorder SD

Rhapsido is first drug cleared for chronic hives disorder SD

Novartis' oral BTK inhibitor Rhapsido has had its label expanded in the US to include a second indication that causes chronic hives.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Discover a new era of healthcare panel engagement

Sponsored

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Pharmaphorum Menu

Digital
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Market Access
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Oncology
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Patients
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
R&D
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Sales & Marketing
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Spotlight on

Sign up for email newsletters and Deep Dive

Get Newsletters

youtube linkedin BlueSky

About us Advertising Contact us

Contribute Cookie Policy Privacy Policy

Terms & Conditions Work for us

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company